Goldman Sachs Group Inc Wave Life Sciences Ltd. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 374,363 shares of WVE stock, worth $5.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374,363
Previous 234,931
59.35%
Holding current value
$5.72 Million
Previous $1.17 Million
161.86%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$278 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$153 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$148 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$103 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$94.1 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.33B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...